Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era
Leukemia. 2022 May;36(5):1416-1420.
doi: 10.1038/s41375-022-01535-y.
Epub 2022 Mar 4.
1 Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. [email protected].
2 Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. [email protected].
3 Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
4 Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
5 Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
6 Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
7 Department of Internal Medical, Reinier de Graaf Gasthuis, Delft, The Netherlands.
8 Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
9 Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
10 Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
11 Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.